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background: To assess the acute and One-Year clinical outcomes of transcatheter pulmonary valve implantation (TPVI) in a multicenter registry 
(MELODY Registry).
methods: Between 12/2006 and 09/2013, 1,003 patients (mean age 21.5±11.4 years) underwent TPVI in 40 cardiac centers. Indications for 
treatment were predominant stenosis (54%), predominant regurgitation (21%), or combined stenosis and regurgitation (25%). We retrospectively 
analyzed procedural details, clinical and echocardiographic outcome parameters. The primary outcome was freedom from death / reoperation / 
reintervention at One-Year (all-cause and TPVI-related); for this analysis, 694 patients were included who reached One-Year follow-up. Secondary 
outcomes included procedural complication rates, rates of endocarditis and stent fractures at One-Year, as well as echocardiographic parameters of 
TPV device performance (peak right ventricular outflow tract (RVOT) velocity and percentage of patients with significant pulmonary regurgitation (PR) 
of grade greater than 2).
results: The invasively measured right ventricular systolic pressure fell from 62±18 mmHg to 43±12 mmHg (p<0.0001) and so did the percentage 
of patients with significant PR of grade greater than 2 (pre: 49% to immediate post-intervention: 1%, p<0.0001). Procedural complications occurred 
in 2.7% (major) and 11.9% (minor) of TPVI procedures, respectively. The One-Year freedom from the combined endpoint was 92.5% for all-cause 
events and 94.2% for TPVI-related events. At One-Year, the rate of endocarditis was 2.7% and the rate of stent fractures was 11%. There was 
sustained hemodynamic performance of the TPVI device at One-Year when compared to immediate post-intervention (peak RVOT velocity: 2.5±0.7 
versus 2.6±0.6 m/s; PR of grade greater than 2: 1% versus 2%).
conclusion: The multicenter MELODY Registry represents the largest patient series after TPVI to date with a follow-up of One-Year and offers the 
great potential for longer clinical observations of this patient population. The analysis of the current data confirms the safety and effectiveness of 
TPVI in clinical practice utilizing the Melody valve.
